Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Board Committee changes

22 Nov 2023 07:00

RNS Number : 2062U
Johnson Matthey PLC
22 November 2023
 

 

22nd November 2023

 

Johnson Matthey Plc

(the Company)

Board Committee changes

 

The Company announces the following changes to the composition of its Board Committees in respect of non-executive directors, effective from 2nd January 2024. These changes align with the Company's overall approach to simplifying the business and enhancing efficiency to deliver its strategic priorities:

 

· Audit Committee: Xiaozhi Liu and Chris Mottershead will step down as members.

 

· Remuneration Committee: Barbara Jeremiah and Rita Forst will step down as members.

 

· Societal Value Committee: Patrick Thomas, Xiaozhi Liu, Chris Mottershead and Doug Webb will step down as members.

 

As previously announced, Chris Mottershead will step down from the Board on 26th January 2024.

 

The Board and Committee membership as at 2nd January 2024 is set out below:

 

Board membership

 

Patrick Thomas

Liam Condon

Stephen Oxley

Barbara Jeremiah

Rita Forst

Jane Griffiths

John O'Higgins

Xiaozhi Liu

Chris Mottershead

Doug Webb

 

Chair

Chief Executive Officer

Chief Financial Officer

Senior Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Board Committee

 

Committee Chair

Members

Audit Committee

 

Doug Webb*

 

Rita Forst

Jane Griffiths

Barbara Jeremiah

John O'Higgins

 

Remuneration Committee

John O'Higgins

Jane Griffiths

Xiaozhi Liu

Chris Mottershead

Doug Webb

 

Nomination Committee

 

Patrick Thomas

 

Rita Forst

Barbara Jeremiah

Jane Griffiths

John O'Higgins

Xiaozhi Liu

Chris Mottershead

Doug Webb

 

Societal Value Committee

Jane Griffiths

 

Liam Condon

Barbara Jeremiah

Rita Forst

John O'Higgins

Stephen Oxley

 

 

* Audit Committee financial expert

 

 

This announcement is made in accordance with Listing Rule 9.6.11.

 

 

ENDS

 

Notes

Biographies of each Board member and the Terms of Reference of each Board Committee are available at www.matthey.com

 

Enquiries: 

 

Simon Price

General Counsel and Company Secretary

+44 20 7269 8052

Martin Dunwoodie

Director of Investor Relations

+44 20 7269 8241

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKDBBDBDBADB
Date   Source Headline
15th Aug 20242:35 pmRNSHolding(s) in Company
15th Aug 20242:25 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20242:47 pmRNSHolding(s) in Company
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 202412:58 pmRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20244:01 pmRNSHolding(s) in Company
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20249:16 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 202410:55 amRNSHolding(s) in Company
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20244:18 pmRNSDirector/PDMR Shareholding
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:35 pmRNSHolding(s) in Company
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202412:53 pmRNSHolding(s) in Company
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20244:25 pmRNSDirector/PDMR Shareholding
18th Jul 202412:46 pmRNSResult of AGM
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
10th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 202410:34 amRNSHolding(s) in Company
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20245:06 pmRNSHolding(s) in Company
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20243:24 pmRNSHolding(s) in Company
3rd Jul 20247:00 amRNSShare buyback programme
2nd Jul 20243:04 pmRNSHolding(s) in Company
1st Jul 20242:38 pmRNSCompletion of Medical Device Components sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.